Kendall Capital Management lifted its stake in shares of HCA Healthcare Inc (NYSE:HCA) by 7.2% in the 1st quarter, Holdings Channel reports. The firm owned 8,545 shares of the company’s stock after buying an additional 575 shares during the quarter. Kendall Capital Management’s holdings in HCA Healthcare were worth $1,114,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently added to or reduced their stakes in the company. Benjamin F. Edwards & Company Inc. purchased a new stake in shares of HCA Healthcare during the fourth quarter worth approximately $25,000. Sontag Advisory LLC purchased a new stake in shares of HCA Healthcare during the fourth quarter worth approximately $26,000. Doyle Wealth Management purchased a new stake in shares of HCA Healthcare during the fourth quarter worth approximately $31,000. Trust Co. of Vermont raised its stake in shares of HCA Healthcare by 165.3% during the fourth quarter. Trust Co. of Vermont now owns 329 shares of the company’s stock worth $41,000 after purchasing an additional 205 shares during the last quarter. Finally, Financial Gravity Wealth Inc. purchased a new stake in shares of HCA Healthcare during the first quarter worth approximately $47,000. Institutional investors and hedge funds own 71.66% of the company’s stock.

In related news, insider Jon M. Foster sold 44,281 shares of the stock in a transaction on Friday, May 10th. The stock was sold at an average price of $122.28, for a total transaction of $5,414,680.68. Following the sale, the insider now owns 96,052 shares of the company’s stock, valued at $11,745,238.56. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 2.70% of the stock is owned by company insiders.

HCA has been the topic of a number of recent analyst reports. Barclays dropped their price objective on HCA Healthcare from $155.00 to $145.00 and set an “overweight” rating on the stock in a report on Wednesday, April 17th. Raymond James raised HCA Healthcare from a “market perform” rating to an “outperform” rating and upped their price objective for the stock from $115.00 to $135.00 in a report on Tuesday, April 23rd. Oppenheimer upped their price objective on HCA Healthcare from $142.00 to $150.00 and gave the stock an “outperform” rating in a report on Wednesday, January 30th. ValuEngine lowered HCA Healthcare from a “buy” rating to a “hold” rating in a report on Wednesday, March 6th. Finally, Deutsche Bank upped their price objective on HCA Healthcare from $160.00 to $165.00 and gave the stock a “buy” rating in a report on Wednesday, May 1st. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and nineteen have given a buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $149.41.

HCA Healthcare stock opened at $127.16 on Tuesday. The firm has a market capitalization of $43.02 billion, a price-to-earnings ratio of 13.02, a PEG ratio of 0.99 and a beta of 0.75. HCA Healthcare Inc has a fifty-two week low of $101.30 and a fifty-two week high of $147.42.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, April 30th. The company reported $2.97 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.31 by $0.66. The company had revenue of $12.52 billion for the quarter, compared to analyst estimates of $12.34 billion. HCA Healthcare had a negative return on equity of 112.65% and a net margin of 7.71%. HCA Healthcare’s revenue was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $3.18 earnings per share. Equities research analysts forecast that HCA Healthcare Inc will post 10.38 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Monday, June 3rd will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.26%. The ex-dividend date of this dividend is Friday, May 31st. HCA Healthcare’s payout ratio is currently 16.38%.

WARNING: This report was first reported by Watch List News and is the property of of Watch List News. If you are viewing this report on another website, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The correct version of this report can be accessed at https://www.watchlistnews.com/kendall-capital-management-has-1-11-million-stake-in-hca-healthcare-inc-hca/3017732.html.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Recommended Story: Cost of Goods Sold (COGS)

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.